Measurable Residual Disease in ALL: Proof of the Principle Transforming Care for Patients With Hematologic Malignancies

Take advantage of these resources for using MRD as a tool during management of patients with ALL. Watch an expert panel discussion or one of several patient-focused short videos read concise expert commentaries and download the slideset and clinical resource PDF.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

No activities added yet

Supporters

This activity is supported by educational grants from

Adaptive Biotechnologies

Amgen, Inc.

Partners

GRACE

ProCE Banner